Valuation: ResMed Inc.

Market Cap 32.34B 28.88B 26.5B 24.1B 45.19B 3,062B 46.09B 316B 128B 1,616B 121B 119B 5,105B P/E 2027 *
19.2x
P/E 2028 * 17.6x
Enterprise Value 31.45B 28.07B 25.76B 23.44B 43.94B 2,977B 44.81B 308B 124B 1,571B 118B 116B 4,963B EV / Sales 2027 *
5.39x
EV / Sales 2028 * 4.99x
Free-Float
74.65%
Yield 2027 *
1.17%
Yield 2028 * 1.27%
1 day-5.77%
1 week-6.82%
Current month-5.77%
1 month+6.05%
3 months+12.32%
6 months+16.46%
Current year-6.90%
1 week 32.8
Extreme 32.8
37.67
1 month 31.52
Extreme 31.52
37.67
Current year 25.5
Extreme 25.5
39.1
1 year 25.5
Extreme 25.5
39.94
3 years 22.19
Extreme 22.19
45.25
5 years 21.14
Extreme 21.14
45.25
10 years 7.15
Extreme 7.15
45.25
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2013
Director of Finance/CFO 41 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 54 25/01/2023
Chairman 84 01/06/1989
Change 5-day change 1-year change 3-year change Capi.($)
-5.77%-6.82% - - 32.34B
-1.49%+0.60%+21.97%+53.94% 258B
-1.29%-1.30%+7.42%+19.15% 163B
+1.51%-2.48%-19.07%+58.49% 150B
+4.70%-3.28%-55.28%-16.06% 60.84B
+1.19%+2.62%-11.10%-8.42% 53.31B
+0.59%+1.69%+10.86%+40.53% 53.03B
-1.47%-2.61%+5.86%+63.16% 50.67B
-1.34%-1.47%+19.82%+65.95% 49.3B
-2.75%-0.68%+31.04%+84.54% 45.46B
Average -0.58%-0.30%+1.28%+40.14% 98.22B
Weighted average by Cap. -0.45%+0.15%+3.77%+41.67%

Financials

2027 *2028 *
Net sales 5.83B 5.21B 4.78B 4.35B 8.15B 552B 8.31B 57.09B 23.01B 292B 21.9B 21.43B 921B 6.2B 5.54B 5.08B 4.62B 8.66B 587B 8.84B 60.67B 24.46B 310B 23.27B 22.77B 979B
Net income 1.69B 1.51B 1.39B 1.26B 2.36B 160B 2.41B 16.56B 6.68B 84.57B 6.35B 6.22B 267B 1.82B 1.63B 1.49B 1.36B 2.54B 172B 2.59B 17.82B 7.18B 90.97B 6.83B 6.69B 287B
Net Debt -897M -801M -735M -668M -1.25B -84.9B -1.28B -8.78B -3.54B -44.81B -3.37B -3.29B -142B -1.43B -1.28B -1.18B -1.07B -2.01B -136B -2.04B -14.04B -5.66B -71.7B -5.39B -5.27B -226B
Projected Income Statement - Annual - ResMed Inc.
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
02/11/26 A$33.46 -5.77% 4,025,488
30/10/26 A$35.51 +0.37% 2,628,627
29/10/26 A$35.38 +0.71% 1,912,360
28/10/26 A$35.13 -1.04% 2,189,739
27/10/26 A$35.50 -0.95% 2,316,053
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ResMed Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
229.94USD
Average target price
265.11USD
Spread / Average Target
+15.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed Inc.